Fig. 2From: Pyrroloquinoline quinone drives ATP synthesis in vitro and in vivo and provides retinal ganglion cell neuroprotectionEffects of PQQ administration on ATP, NAD, mitochondrial membrane potential levels and mitochondrial function in vitro. A ATP and B NAD content in dissociated mouse brain cortical cells incubated with different doses of PQQ (0.1, 0.5, 1, 5, 10, 50 µM) for 2 h. n = 4 different cell suspensions from different hemispheres. C ATP content in dissociated retinal and superior colliculus cells and in isolated optic nerves incubated with 50 µM PQQ for 2 h. The red inset shows a zoom of the graph related to the ATP content in superior colliculus. n = 5 retinal replicates made by 2 pooled retinas, 5 optic nerve replicates made of isolated segments cut to 3 mm length, 5 superior colliculus replicates. D Mitochondrial membrane potential (ΔΨ) levels in dissociated brain cortical cells incubated with several concentrations of PQQ (0.5, 5, 50 µM) for 2 h. n = 4 different cell suspensions from different hemispheres. E ΔΨ levels in dissociated retinal and superior colliculus cells and in isolated optic nerves incubated with 50 µM PQQ for 2 h. n = 8 retinal replicates made by 2 pooled retinas, 5 optic nerve replicates made of isolated segments cut to 3 mm length, 5 superior colliculus replicates. F–I Mitochondrial Complex (C) II (F), III (G), IV (H) and citrate synthase (CS; I) activity in dissociated cortical cells incubated with 50 µM PQQ for 2 h. n = 6 different cell suspensions from different hemispheres. *p < 0.05, **p < 0.01 and ***p < 0.001 versus controlBack to article page